Theratechnologies Announces FDA's Final Decision on its New Drug Application for Tesamorelin
November 11th, 2010 at 8:30am ET
About Theratechnologies
Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers and develops innovative therapeutic products, with an emphasis on peptides, for commercialization. The Company targets unmet medical needs in specialty markets where it can retain all or part of the commercial rights to its products. Its most advanced compound, tesamorelin, is an analogue of the human growth hormone releasing factor.
Visit our web site at www.theratech.com.
The following information is required to view this webcast.
Please complete all of the information to continue.